Welcome to our dedicated page for Bwx Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on Bwx Technologies stock.
BWX Technologies Inc (BWXT) delivers mission-critical nuclear components and technical services for government and commercial sectors worldwide. This dedicated news hub provides investors and industry professionals with authoritative updates directly from the company and verified sources.
Access real-time announcements including earnings reports, government contract awards, and R&D breakthroughs in nuclear manufacturing. Track developments across BWXT's core operations: precision component production for defense programs, radiopharmaceutical innovations, and environmental remediation projects.
Our curated feed simplifies monitoring of strategic partnerships, regulatory milestones, and technology advancements in nuclear operations. Bookmark this page for streamlined access to BWXT's official financial disclosures, facility updates, and leadership communications - all essential for understanding this specialized industrial leader.
Rhea-AI Summary
BWX Technologies, Inc. (BWXT) will release its fourth quarter and full-year 2023 results on February 27, 2024, followed by a conference call and an Investor Day on February 28, 2024. The company encourages participants to join the call and view the presentation online. The event will feature presentations by BWXT's President and CEO, CFO, and other leaders, followed by a live Q&A session. In-person attendance for the Investor Day is by invitation only.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
-
Rhea-AI Summary
BWX Technologies, Inc. (NYSE: BWXT) announced the appointment of Nicole W. Piasecki, a former Boeing executive, to its board of directors effective January 2, 2024. Piasecki brings 25 years of experience in senior leadership positions at The Boeing Company and currently serves on the boards of BAE Systems and Weyerhaeuser Company. Her expertise in the aerospace and defense sector, as well as international markets, will be valuable for BWXT's growth goals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
-
Rhea-AI Summary
BWX Technologies, Inc. (NYSE: BWXT) will host an Investor Day on February 28, 2024, at the New York Stock Exchange. The event will feature presentations by President & CEO Rex D. Geveden and CFO Robb A. LeMasters, followed by a live Q&A session. The webcast, replay, and presentation slides will be available on BWXT’s Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
Rhea-AI Summary
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) and BWXT Medical Ltd. have entered an agreement for the supply of generators to produce actinium-225, a medical isotope used in cancer treatment clinical trials. The agreement allows Fusion to access high-specific activity generator technology to produce actinium-225 at its GMP manufacturing facility, supporting the company's advancing pipeline of targeted alpha therapies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
-
Rhea-AI Summary
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) and BWXT Medical Ltd. have entered into a new agreement for the supply of generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials. This collaboration enables Fusion to produce high purity actinium-225 at the Company's GMP manufacturing facility, further solidifying BWXT Medical's position as a global leader in medical isotope supply. Actinium-225 is an alpha-emitting isotope used in Fusion's targeted alpha therapies (TATs) to kill cancer cells while minimizing the impact to healthy tissues. The agreement allows Fusion to have onsite production of actinium-225, providing superior flexibility in manufacturing schedules and increased capacity to support the clinical pipeline.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
-
Rhea-AI Summary
BWXT Technologies, Inc. (NYSE: BWXT) has been chosen as the nuclear fuel and components manufacturer for the Air Force Research Laboratory’s JETSON program. This program aims to advance high-power nuclear electric power and propulsion technologies for spacecraft design, offering 6-20 kWe of electricity, four times more than traditional solar arrays without continuous sunlight. BWXT will work with Lockheed Martin and Space Nuclear Power Corporation to lead manufacturing and testing activities, supporting design and system integration.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
Rhea-AI Summary
BWX Technologies, Inc. reported 3Q23 revenues of $590.0 million, net income of $60.4 million, and adjusted EBITDA of $106.5 million. The company signed multiple agreements to progress microreactor development for commercial applications. They narrowed their 2023 non-GAAP EPS guidance to $2.90-$2.95 and provided preliminary 2024 guidance for mid-single-digit growth in non-GAAP EPS and adjusted EBITDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.11%
Tags
-
Rhea-AI Summary
BWXT subsidiary Nuclear Fuel Services, Inc. has been awarded a $300 million contract to manufacture naval nuclear reactor fuel for the U.S. Naval Nuclear Propulsion Program. The contract includes fuel for submarines and aircraft carriers, including the Navy's Columbia-class submarines. The work is expected to be completed by mid-2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.39%
Tags
-
Rhea-AI Summary
BWX Technologies, Inc. to release Q3 2023 results on November 1, 2023, after market close. Conference call at 5:00 p.m. EDT. Replay available on website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
Rhea-AI Summary
Crowley and BWX Technologies team up to develop a ship concept for alternative energy generation
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.33%
Tags
Bwx Technologies Inc